Ritonavir
-
{
- All
- News
- Videos
-
In Fresh Guidelines, Health Ministry Recommends Anti-Malarial Drug For Covid-19; Removes Anti-HIV Drugs
- Wednesday April 1, 2020
- Author: PTI
The ministry said the drug is presently not recommended for children aged less than 12 and pregnant and lactating women
-
www.ndtvprofit.com
-
Aurobindo Pharma Gets USFDA Nod for Anti-HIV Tablets
- Saturday February 27, 2016
- Press Trust of India
The United States Food and Drug Administration (USFDA) has given tentative approval to Aurobindo Pharma's Ritonavir tablets in the strength of 100 mg, FDA said on its website.
-
www.ndtvprofit.com
-
Cipla Gets US Regulator's Nod for Lopinavir, Ritonavir Oral Pellets
- Wednesday June 3, 2015
Cipla MD & Global CEO Subhanu Saxena said: "This innovative way of drug delivery through oral pellets for some of society's youngest AIDS sufferers reiterates our commitment to provide access to life saving medicines in the fight against HIV/ AIDS."
-
www.ndtvprofit.com
-
India rejects US company's patent for anti-HIV drugs
- Monday January 10, 2011
- India News | NDTV Correspondent
What serves as one of the biggest threats against people living with HIV AIDS is multinational drug companies, producing lifesaving drugs, pushing for patents so generic companies cannot produce them at much lower prices. However, in a much needed relief to Indian pharmaceutical companies as well as patients, India rejected a patent application fil...
-
www.ndtv.com
-
In Fresh Guidelines, Health Ministry Recommends Anti-Malarial Drug For Covid-19; Removes Anti-HIV Drugs
- Wednesday April 1, 2020
- Author: PTI
The ministry said the drug is presently not recommended for children aged less than 12 and pregnant and lactating women
-
www.ndtvprofit.com
-
Aurobindo Pharma Gets USFDA Nod for Anti-HIV Tablets
- Saturday February 27, 2016
- Press Trust of India
The United States Food and Drug Administration (USFDA) has given tentative approval to Aurobindo Pharma's Ritonavir tablets in the strength of 100 mg, FDA said on its website.
-
www.ndtvprofit.com
-
Cipla Gets US Regulator's Nod for Lopinavir, Ritonavir Oral Pellets
- Wednesday June 3, 2015
Cipla MD & Global CEO Subhanu Saxena said: "This innovative way of drug delivery through oral pellets for some of society's youngest AIDS sufferers reiterates our commitment to provide access to life saving medicines in the fight against HIV/ AIDS."
-
www.ndtvprofit.com
-
India rejects US company's patent for anti-HIV drugs
- Monday January 10, 2011
- India News | NDTV Correspondent
What serves as one of the biggest threats against people living with HIV AIDS is multinational drug companies, producing lifesaving drugs, pushing for patents so generic companies cannot produce them at much lower prices. However, in a much needed relief to Indian pharmaceutical companies as well as patients, India rejected a patent application fil...
-
www.ndtv.com